Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Larotrectinib (laro) long-term efficacy and safety in patients (pts) with tropomyosin receptor kinase (TRK) fusion thyroid carcinoma (TC)
- Authors
- Cabanillas, ME[Cabanillas, Maria E.]; Lin, JJ[Lin, Jessica Jiyeong]; Brose, MS[Brose, Marcia S.]; McDermott, RS[McDermott, Raymond S.]; Almubarak, M[Almubarak, Mohammed]; Bauman, JR[Bauman, Jessica R.]; Casanova, M[Casanova, Michela]; Kummar, S[Kummar, Shivaani]; Lee, SH[Lee, Se-Hoon]; Leyvraz, S[Leyvraz, Serge]; Oh, DY[Oh, Do-Youn]; Shen, L[Shen, Lin]; Norenberg, R[Norenberg, Ricarda]; Bernard-Gauthier, V[Bernard-Gauthier, Vadim]; Mussi, CE[Mussi, Chiara E.]; Hong, DS[Hong, David S.]; Drilon, AE[Drilon, Alexander E.]; Waguespack, SG[Waguespack, Steven G.]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.